Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, par value 0.002 GBP per share
-
Shares outstanding
-
147,336,360
-
Total 13F shares
-
5,295,653
-
Share change
-
-6,375,011
-
Total reported value
-
$59,840,427
-
Put/Call ratio
-
28%
-
Price per share
-
$11.30
-
Number of holders
-
6
-
Value change
-
-$40,571,148
-
Number of buys
-
2
-
Number of sells
-
8
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) as of Q1 2024
As of 31 Mar 2024,
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,295,653 shares.
The largest 6 holders included
PERCEPTIVE ADVISORS LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, Royal Bank of Canada, and NBC SECURITIES, INC..
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.